En Es
Categories

Industry News

First Deep Learning-Based Image Reconstruction Technology Receives FDA Clearance

By Medimaging International staff writers
03 May 2019

Image: The Revolution Apex CT with Deep Learning Image Reconstruction (DLIR) technology (Photo courtesy of GE Healthcare).GE Healthcare (Chicago, IL, USA) has received 510(k) clearance from the U.S. FDA for its Deep Learning Image Reconstruction (DLIR) engine on its new Revolution Apex CT device, and as an upgrade to its Revolution CT system in the U.S. DLIR is a next generation image reconstruction option that uses a dedicated deep neural network (DNN) to generate TrueFidelity CT Images. These TrueFidelity CT Images have the potential to improve reading confidence in a wide range of clinical applications such as head, whole body and cardiovascular, for patients of all ages.

The FDA has also granted 510(k) clearance to three additional CT applications introduced recently by GE Healthcare at RSNA 2018. They include Bone VCAR, Thoracic VCAR with GSI Pulmonary Perfusion, and SnapShot Freeze 2. Both Bone VCAR and SnapShot Freeze 2 are based on the Edison platform that helps accelerate the development and adoption of Artificial Intelligence (AI) technology and empower providers to deliver faster, more precise care.

Bone VCAR uses a deep-learning algorithm to automatically identify and label the vertebrae for faster spine assessment and improve reporting efficiency. SnapShot Freeze 2 is an intelligent motion correction algorithm that takes cardiac imaging to the next level by expanding the breadth of intelligent motion correction applications, further enhancing clinical performance and introducing whole heart motion correction. Thoracic VCAR with GSI pulmonary perfusion provides automated segmentation and measurements for assessment and follow-up of thoracic diseases. It now also includes dedicated GSI Pulmonary Perfusion, a one-click protocol to assist in the identification of variations of relative perfusion distribution in the lungs. Thoracic diseases that may be associated with changes in perfusion include pulmonary embolism or chronic obstructive pulmonary disease (COPD).

“We are proud to usher in the next generation of image reconstruction,” said Mike Barber, president and CEO of MICT, GE Healthcare. “Our Deep Learning Image Reconstruction engine combines the ground truth image quality of filtered back projection (FBP) with the low dose capabilities of iterative reconstruction to produce TrueFidelity CT Images. These images offer outstanding image quality and restore noise texture to improve radiologists’ confidence in diagnosing a wide range of clinical cases.”

“Physicians that have reviewed our new TrueFidelity CT Images consistently say they are among the best CT images they have ever seen, and our 510(k)-reader study also demonstrated this improvement,” said Scott Schubert, general manager of global premium CT, GE Healthcare. “Revolution Apex delivers CT technology innovations including the Quantix 160 x-ray tube and Deep Learning Image Reconstruction, and we are pleased to bring these innovations as optional upgrades to our Revolution CT users as well.”



E-mail Print
FaceBook Twitter Google+ Linked in

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
More info

More articles about GE Healthcare

26 Sep 2019
GE Healthcare and Affibody Collaborate to Develop PET Imaging Tracers
GE Healthcare and Affibody AB have entered into a strategic collaboration to develop and commercialize Affibody-based PET imaging tracers, with initial focus on HER2 and PD-L1.
Read More
22 Aug 2019
GE Healthcare Partners with Fujitsu to Develop AI for Spotting Brain Aneurysms
GE Healthcare has entered into a research collaboration with Fujitsu Australia to diagnose and monitor brain aneurysms on scans faster and more efficiently by using artificial intelligence.
Read More
18 Oct 2018
GE Healthcare and ESR Enter AI Partnership for ECR 2019
GE Healthcare (Chicago, IL, USA) and the European Society of Radiology (Vienna, Austria) will be partnering on artificial intelligence (AI) for the upcoming European Congress of Radiology (ECR) to be held in Vienna, Austria on February 27-March 3, 2019. The partnership will include joint sessions on AI and a dedicated space at GE Healthcare’s booth where visitors will be able to experience the AI transformation through interactive tools.
Read More
15 Oct 2018
GE Healthcare to Implement First AI-Powered Hospital Command Centers
GE Healthcare is collaborating with hospital service providers in Europe and the US for implementing an artificial intelligence (AI)-powered command center to effectively and efficiently synchronize all elements of a patient's hospital experience. The AI-powered system will support caregivers to enhance patient safety, orchestrate seamless care delivery and get patients back home sooner.
Read More
26 Jun 2018
GE to Spin Off Healthcare Business
In line with a sweeping strategic reorganization, General Electric Company has announced the decision to spin off its Healthcare business segment as an independent company. The move comes on the heels of a lengthy managerial review conducted by GE management under newly appointed CEO John Flannery.
Read More
16 Jan 2018
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
GE Healthcare and Roche have entered into a strategic, long-term partnership to jointly develop and co-market digital clinical decision support solutions. Initially, the partnership will focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.
Read More
06 Dec 2017
GE Healthcare and Nuance Partner with NVIDIA to Bring AI to Medical Imaging
Healthcare-solution providers GE Healthcare and Nuance Communications, Inc., have partnered with NVIDIA, a leader in visual computing technologies, for using the company’s deep learning platform to bring Artificial Intelligence (AI) to medical imaging.
Read More
05 Dec 2017
GE Launches Drawbridge Health to Transform Blood Collection
GE Healthcare has introduced Drawbridge Health, a privately held healthcare technology company, which is developing a people-friendly system to integrate draw, collection and stabilize blood samples into a single device. The technology which integrates engineering and proprietary chemistries is also being developed to support room temperature shipping and streamlined downstream processing, thus ensuring reliable, accurate results.
Read More

Additional news

03 Oct 2019
Researchers Use Machine Learning to Increase Resolution of OCT Imaging
Biomedical engineers at Duke University have devised a method for increasing the resolution of optical coherence tomography (OCT) down to a single micrometer scale in all directions.
Read More
03 Oct 2019
New Mount Sinai BMEII Center to Focus on AI in Advanced Imaging
The Mount Sinai Health System has announced the creation of the Biomedical Engineering and Imaging Institute (BMEII), the first of its kind in New York City, and one of the few in the world.
Read More
03 Oct 2019
NIH Awards USD 1.6 Million Grant to Subtle Medical
The National Institutes of Health has awarded healthcare technology company Subtle Medical a Fast-Track Small Business Innovation Research (SBIR) grant of USD 1.6 million.
Read More
01 Oct 2019
RSNA Announces Intracranial Hemorrhage AI Challenge
The Radiological Society of North America has launched its third annual artificial intelligence (AI) challenge: the RSNA Intracranial Hemorrhage Detection and Classification Challenge.
Read More
01 Oct 2019
Artificial Intelligence Accurately Predicts Radiation Treatment Side Effects
Researchers from the University of Texas MD Anderson Cancer Center have demonstrated that a sophisticated computer model can accurately predict two of the most challenging side effects associated with radiation therapy for head and neck cancer.
Read More
01 Oct 2019
Global Microfluidic Immunoassay Market to Reach USD 2 Billion by 2025
The global microfluidic immunoassay market is expected to grow at a CAGR of 12.7% from 2019 to USD 2.0 billion by 2025, driven by greater benefits offered by Lab-on-chip (LOC) over conventional quantifiable technologies, the growing need for point-of-care (POC) in low-resource settings, and increasing research activities in the field of microfluidic technology.
Read More
27 Sep 2019
Agfa Demonstrates AI-Powered Intelligent DR Solutions at RSNA 2019
Agfa NV will present its intelligent radiography powered by the MUSICA Acquisition Workstation, the digital Nerve Center of every Agfa DR system, including the launch of a new, groundbreaking direct radiography (DR) unit at RSNA 2019, to be held December 1-6, in Chicago, IL, USA.
Read More
26 Sep 2019
FUJIFILM SonoSite Collaborates with AI2 Incubator to Improve Image Analysis
FUJIFILM SonoSite has entered into a collaboration with the Allen Institute for Artificial Intelligence for interpreting ultrasound images with artificial intelligence (AI), enabling new ultrasound applications and enhanced accuracy.
Read More
18 Sep 2019
AI Solution Supporting Wins Best New Radiology Solution Award
An FDA-cleared artificial intelligence (AI) solution that supports breast cancer detection in 3D tomosynthesis has been selected as the winner of “Best New Radiology Solution” Award in the 2019 MedTech Breakthrough Awards program.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions